Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Efeitos do Yoga na Qualidade de Vida de Pacientes com Câncer de Mama

23 de setembro de 2026 atualizado por: Andreas Michalsen, Charite University, Berlin, Germany

Effects of Two Different Online Yoga Interventions on the Quality of Life of Breast Cancer Patients Compared With Waiting List - a Three-arm Randomized Controlled Trial

This study investigates the effects of two different online yoga interventions on the health-related quality of life in breast cancer patients. Qualitative and quantitative data will be collected.

Visão geral do estudo

Status

Recrutamento

Descrição detalhada

In this randomized controlled trial breast cancer patients will be randomized into three treatment arms:

  • Intervention group 1 will receive an Iyengar yoga intervention online in a group setting, based on the internationally renowned yoga school of B.K.S. Iyengar, which in the context of this study mainly includes physical and relaxation exercises.
  • Intervention group 2 will receive a meditative yoga intervention online including physical and meditation exercises and also ideologically neutral explanations of the ethical aspects of yoga.
  • Group 3 consists of a waiting list control group, combined with the offer to participate in a yoga intervention after 6 months.

Tipo de estudo

Intervencional

Inscrição (Estimado)

138

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • State of Berlin
      • Berlin, State of Berlin, Alemanha, 14109
        • Recrutamento
        • Charite University
        • Contato:
        • Investigador principal:
          • Andreas Michalsen, Prof.Dr.

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 75 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Fêmea

Descrição

Inclusion Criteria:

  • Histologically confirmed diagnosis of non-metastatic breast cancer (TNM stage I-III) up to 5 years after diagnosis
  • Primary therapy completed for at least 3 months
  • Limitation of the quality of life due to the cancer (indication of at least 4 out of 10 points on the numerical analogue scale)
  • Willingness to participate in the study and signed informed consent.

Exclusion Criteria:

  • Current or planned chemotherapy, radiation or surgery
  • Severe physical or psychopharmacologically treated psychiatric comorbidity due to which a patient is unable to participate in the study
  • Pregnancy/breastfeeding
  • Participation in other clinical trials with behavioral, psychological, or complementary medicine interventions
  • Immobility or limitation for gymnastic exercise due to orthopedic, neurologic, or other medical cause
  • regular meditation practice >2x/month
  • regular yoga practice >2x/month

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Iyengar yoga

Intervention group 1 receives an Iyengar yoga intervention online in a group setting, based on the internationally renowned yoga school of B.K.S. Iyengar, which in the context of this study primarily includes physical and relaxation exercises.

Iyengar Yoga focuses on the correct alignment of the body while practicing the physical exercises of yoga. Props are used to support the body in finding the right alignment. Relaxation is also part of this intervention. Participiants receive 1x90 min guided yoga class per week for 8 weeks and are encouraged to continue their practice at home daily for at least 30 minutes.

Experimental: Meditative yoga

Intervention group 2 receives an Integrative yoga intervention online including physical and meditation exercises as well as ideologically neutral explanations of the ethical aspects of Yoga.

Meditative Yoga in the context of this study means practicing the physical exercises of yoga as well as meditation. Additionally, each week one of the yamas/niyamas, which are ethical principles to live by in the Yoga philosophy, will be presented at the beginning of each class and will form the theme of the class. Participants receive 1x90 min guided yoga class per week for 8 weeks and are encouraged to continue their practice at home daily for at least 30 minutes.

Sem intervenção: Waitlist Control Group

Group 3 consists of a waitlist control group. Participants will be offered the opportunity to attend a yoga intervention after 4 months. The patients in this waiting list control group are allowed to choose the yoga course after 6 months.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)
Prazo: Date of inclusion (baseline), after 8 weeks

Assessing full scale, range 0-40, higher score meaning a better outcome

Date of inclusion (baseline), after 8 weeks

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)
Prazo: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Assessing full scale, range 0-40, higher score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Functional Assessment of Cancer Therapy: Fatigue (FACIT-F)
Prazo: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Assessing full scale, range 0-52, higher score meaning a better outcom

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Perceived Stress Scale (PSS-10)
Prazo: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Assessing full scale, range 0-40, lower score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Flourishing Scale (FS-D)
Prazo: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Assessing full scale, range 8-56, higher score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Self-Compassion Scale (SCS-D)
Prazo: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Mean score of 12 items, range 1-5, higher score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Self-Efficacy Scale (ASKU)
Prazo: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Mean score of 3 items, range 1-5, higher score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Sociodemographic measures
Prazo: Date of inclusion (baseline)

Age, education level, personal income, household income, employment status, job description, marital status, household members, days of sick leave past 3 months

Date of inclusion (baseline)
Behavioral questions: cigarettes
Prazo: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Number of cigarettes on average per day in the last month

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Behavioral questions: alcohol
Prazo: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Number of alcoholic beverages on average per week in the last month

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Expectation question
Prazo: Date of inclusion (baseline)

expectation of effectiveness of the intervention on a 5-point likert scale, how they expect to handle the intervention on a 5-point likert scale, higher score meaning better outcome

Date of inclusion (baseline)
Behavioural question
Prazo: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

diet

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Behavioural question 2
Prazo: Date of inclusion (baseline)

Practice of other mindfulness practices besides Yoga

Date of inclusion (baseline)
Behavioural question 3
Prazo: Date of inclusion (baseline)

Yoga styles were practiced before

Date of inclusion (baseline)
Behavioural question 4
Prazo: Date of inclusion (baseline)

If and how often yoga is practiced regularly

Date of inclusion (baseline)
Functional Assessment of Cancer Therapy - General (FACT-G)
Prazo: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Assessing full scale, range 0-108, higher score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Yama/Niyama Questionnaire - YaNiQ
Prazo: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Assessing full scale, range 0-100, higher score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Hospital Anxiety and Depression Scale (HADS)
Prazo: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Assessing full scale, range 0-42, lower score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Qualitative interviews
Prazo: 8 weeks after inclusion

Qualitative assessment will be carried out in qualitative interviews in 20 patients participating in the study. The interviews will be recorded, transcribed and analyzed with qualitative content analysis.

8 weeks after inclusion
Heart Rate Variability (HRV)
Prazo: Date of inclusion (baseline), after 8 weeks

24h measuring by Faros 180

Date of inclusion (baseline), after 8 weeks

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

9 de maio de 2022

Conclusão Primária (Estimado)

1 de abril de 2027

Conclusão do estudo (Estimado)

1 de dezembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

7 de abril de 2022

Enviado pela primeira vez que atendeu aos critérios de CQ

7 de abril de 2022

Primeira postagem (Real)

14 de abril de 2022

Atualizações de registro de estudo

Última Atualização Postada (Real)

25 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

23 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Palavras-chave

Outros números de identificação do estudo

  • YOMA

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever